{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T15:36:51Z","timestamp":1784561811228,"version":"3.55.0"},"reference-count":77,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Letters"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1016\/j.canlet.2023.216406","type":"journal-article","created":{"date-parts":[[2023,9,19]],"date-time":"2023-09-19T21:02:13Z","timestamp":1695157333000},"page":"216406","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"special_numbering":"C","title":["Skin cancer prevention \u2013 Recent advances and unmet challenges"],"prefix":"10.1016","volume":"575","author":[{"given":"Mahsa","family":"Mortaja","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7913-2641","authenticated-orcid":false,"given":"Shadmehr","family":"Demehri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.canlet.2023.216406_bib1","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.fsc.2012.07.004","article-title":"Epidemiology and economic burden of nonmelanoma skin cancer","volume":"20","author":"Cakir","year":"2012","journal-title":"Facial Plast Surg Clin North Am"},{"key":"10.1016\/j.canlet.2023.216406_bib2","doi-asserted-by":"crossref","first-page":"4337","DOI":"10.1038\/s41598-021-83502-8","article-title":"The incidence and clinical analysis of non-melanoma skin cancer","volume":"11","author":"Ciazynska","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.canlet.2023.216406_bib3","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s13005-016-0106-0","article-title":"Basal cell carcinoma, squamous cell carcinoma and melanoma of the head and face","volume":"12","author":"Feller","year":"2016","journal-title":"Head Face Med."},{"key":"10.1016\/j.canlet.2023.216406_bib4","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1146\/annurev-pathol-042320-120056","article-title":"Cutaneous squamous cell carcinoma: the frontier of cancer immunoprevention","volume":"17","author":"Chang","year":"2022","journal-title":"Annu. Rev. Pathol."},{"key":"10.1016\/j.canlet.2023.216406_bib5","series-title":"Squamous Cell Skin Cancer.\u201d StatPearls, StatPearls Publishing","first-page":"31","author":"Howell","year":"2023"},{"key":"10.1016\/j.canlet.2023.216406_bib6","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1111\/j.0303-6987.2006.00516.x","article-title":"Cutaneous squamous cell carcinoma: a comprehensive clinicopathologic classification--part two","volume":"33","author":"Cassarino","year":"2006","journal-title":"J. Cutan. Pathol."},{"key":"10.1016\/j.canlet.2023.216406_bib7","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1097\/PAP.0000000000000157","article-title":"Cutaneous squamous cell carcinoma: review of the eighth edition of the American joint committee on cancer staging guidelines, prognostic factors, and histopathologic variants","volume":"24","author":"Motaparthi","year":"2017","journal-title":"Adv. Anat. Pathol."},{"key":"10.1016\/j.canlet.2023.216406_bib8","first-page":"CD011901","article-title":"Cochrane Skin Cancer Diagnostic Test Accuracy, Visual inspection and dermoscopy, alone or in combination, for diagnosing keratinocyte skin cancers in adults","volume":"12","author":"Dinnes","year":"2018","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.canlet.2023.216406_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.xjidi.2022.100126","article-title":"Cutaneous squamous cell carcinoma arising in immunosuppressed patients: a systematic review of tumor profiling studies","volume":"2","author":"Blue","year":"2022","journal-title":"JID Innov"},{"key":"10.1016\/j.canlet.2023.216406_bib10","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1111\/bjd.15950","article-title":"Research gaps in the management and prevention of cutaneous squamous cell carcinoma in organ transplant recipients","volume":"177","author":"Blomberg","year":"2017","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.canlet.2023.216406_bib11","doi-asserted-by":"crossref","first-page":"2309","DOI":"10.1016\/j.jid.2017.06.025","article-title":"Survival of patients with cutaneous squamous cell carcinoma: results of a prospective cohort study","volume":"137","author":"Eigentler","year":"2017","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.canlet.2023.216406_bib12","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1097\/DSS.0000000000000488","article-title":"Lymph node metastasis in cutaneous head and neck squamous cell carcinoma","volume":"41","author":"Silberstein","year":"2015","journal-title":"Dermatol. Surg."},{"key":"10.1016\/j.canlet.2023.216406_bib13","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1056\/NEJMoa2203086","article-title":"Nicotinamide for skin-cancer chemoprevention in transplant recipients","volume":"388","author":"Allen","year":"2023","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.canlet.2023.216406_bib14","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23158530","article-title":"Immunotherapy for the treatment of squamous cell carcinoma: potential benefits and challenges","volume":"23","author":"Ansary","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.canlet.2023.216406_bib15","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1056\/NEJMra1708701","article-title":"Update on keratinocyte carcinomas","volume":"379","author":"Nehal","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.canlet.2023.216406_bib16","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1001\/jamadermatol.2015.1187","article-title":"Incidence estimate of nonmelanoma skin cancer (keratinocyte carcinomas) in the U.S. Population","volume":"151","author":"Rogers","year":"2012","journal-title":"JAMA dermatology"},{"key":"10.1016\/j.canlet.2023.216406_bib17","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1111\/bjd.15324","article-title":"Cutaneous squamous cell carcinoma: an epidemiological review","volume":"177","author":"Green","year":"2017","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.canlet.2023.216406_bib18","doi-asserted-by":"crossref","first-page":"3124","DOI":"10.1016\/j.transproceed.2014.09.170","article-title":"Coordinator transplant section of the Belgian transplant, organ donation and transplantation statistics in Belgium for 2012 and 2013","volume":"46","author":"Desschans","year":"2014","journal-title":"Transplant. Proc."},{"key":"10.1016\/j.canlet.2023.216406_bib19","series-title":"Transplant Trends","author":"Network","year":"2022"},{"key":"10.1016\/j.canlet.2023.216406_bib20","doi-asserted-by":"crossref","first-page":"330","DOI":"10.5826\/dpc.0804a18","article-title":"Degree of differentiation of cutaneous squamous cell carcinoma: a comparison between a Swedish cohort of organ transplant recipients and immunocompetent patients","volume":"8","author":"Stenman","year":"2018","journal-title":"Dermatol. Pract. Concept."},{"key":"10.1016\/j.canlet.2023.216406_bib21","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1097\/01.tp.0000209921.60305.d9","article-title":"Subsequent skin cancers in kidney and heart transplant recipients after the first squamous cell carcinoma","volume":"81","author":"Euvrard","year":"2006","journal-title":"Transplantation"},{"key":"10.1016\/j.canlet.2023.216406_bib22","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21239300","article-title":"Immune checkpoint blockade in advanced cutaneous squamous cell carcinoma: what do we currently know in 2020?","volume":"21","author":"Wessely","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.canlet.2023.216406_bib23","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1080\/14740338.2022.1993819","article-title":"Cemiplimab for the treatment of advanced cutaneous squamous cell carcinoma","volume":"21","author":"Villani","year":"2022","journal-title":"Expert Opin Drug Saf"},{"key":"10.1016\/j.canlet.2023.216406_bib24","doi-asserted-by":"crossref","first-page":"611","DOI":"10.2217\/fon-2020-0823","article-title":"Comparative efficacy of cemiplimab versus other systemic treatments for advanced cutaneous squamous cell carcinoma","volume":"17","author":"Keeping","year":"2021","journal-title":"Future Oncol."},{"key":"10.1016\/j.canlet.2023.216406_bib25","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1084873","article-title":"Understanding the squamous cell carcinoma immune microenvironment","volume":"14","author":"Saeidi","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.canlet.2023.216406_bib26","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1634\/theoncologist.2019-0659","article-title":"The safety and efficacy of checkpoint inhibitors in transplant recipients: a case series and systematic review of literature","volume":"25","author":"Kumar","year":"2020","journal-title":"Oncol."},{"issue":"Suppl 1","key":"10.1016\/j.canlet.2023.216406_bib27","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1111\/jdv.17407","article-title":"Treatment of metastatic cutaneous squamous cell carcinoma in a solid organ transplant recipient with programmed death-1 checkpoint inhibitor therapy","volume":"36","author":"O'Connell","year":"2022","journal-title":"J. Eur. Acad. Dermatol. Venereol. : JEADV"},{"key":"10.1016\/j.canlet.2023.216406_bib28","doi-asserted-by":"crossref","first-page":"406","DOI":"10.6004\/jnccn.2022.7009","article-title":"Immune checkpoint inhibitor use in solid organ transplant recipients: a systematic review","volume":"20","author":"Portuguese","year":"2022","journal-title":"J Natl Compr Canc Netw"},{"key":"10.1016\/j.canlet.2023.216406_bib29","series-title":"Actinic Keratosis, StatPearls, Treasure Island (FL)","author":"Marques","year":"2022"},{"key":"10.1016\/j.canlet.2023.216406_bib30","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1007\/s40257-018-0348-7","article-title":"Field cancerization therapies for management of actinic keratosis: a narrative review","volume":"19","author":"Jetter","year":"2018","journal-title":"Am. J. Clin. Dermatol."},{"key":"10.1016\/j.canlet.2023.216406_bib31","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1111\/bjd.12420","article-title":"The natural history of actinic keratosis: a systematic review","volume":"169","author":"Werner","year":"2013","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.canlet.2023.216406_bib32","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1111\/bjd.15019","article-title":"Actinic keratosis-related signs predictive of squamous cell carcinoma in renal transplant recipients: a nested case-control study","volume":"176","author":"Jiyad","year":"2017","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.canlet.2023.216406_bib33","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1093\/ndt\/13.6.1374","article-title":"Skin cancers in transplant patients","volume":"13","author":"Dreno","year":"1998","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.canlet.2023.216406_bib34","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1001\/jamainternmed.2016.5008","article-title":"Skin cancer-the importance of prevention","volume":"176","author":"Linos","year":"2016","journal-title":"JAMA Intern. Med."},{"key":"10.1016\/j.canlet.2023.216406_bib35","series-title":"Skin Cancer PreventionStatPearls","volume":"8","author":"Guerra","year":"2023"},{"key":"10.1016\/j.canlet.2023.216406_bib36","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1034\/j.1600-0781.2002.00768.x","article-title":"The importance of using broad spectrum SPF 30+ sunscreens in tropical and subtropical climates","volume":"18","author":"Poon","year":"2002","journal-title":"Photodermatol. Photoimmunol. Photomed."},{"key":"10.1016\/j.canlet.2023.216406_bib37","doi-asserted-by":"crossref","first-page":"e435","DOI":"10.1016\/j.lpm.2014.08.008","article-title":"Cutaneous HPV and skin cancer","volume":"43","author":"Accardi","year":"2014","journal-title":"Presse Med."},{"key":"10.1016\/j.canlet.2023.216406_bib38","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1111\/tri.13952","article-title":"E.W.o.t.T.L.J.p. for, Managing immunosuppressive therapy in potentially cured post-kidney transplant cancer (excluding non-melanoma skin cancer): an overview of the available evidence and guidance for shared decision-making","volume":"34","author":"Hellemans","year":"2021","journal-title":"Transpl. Int."},{"key":"10.1016\/j.canlet.2023.216406_bib39","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1111\/ajt.13596","article-title":"Immunosuppressive medications and squamous cell skin carcinoma: nested case-control study within the skin cancer after organ transplant (SCOT) cohort","volume":"16","author":"Coghill","year":"2016","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.canlet.2023.216406_bib40","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1001\/jamadermatol.2017.3631","article-title":"Affairs keratinocyte carcinoma chemoprevention trial, chemoprevention of basal and squamous cell carcinoma with a single course of fluorouracil, 5%, cream: a randomized clinical trial","volume":"154","author":"Weinstock","year":"2018","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.canlet.2023.216406_bib41","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1097\/TP.0000000000002641","article-title":"Interventions to prevent nonmelanoma skin cancers in recipients of a solid organ transplant: systematic review of randomized controlled trials","volume":"103","author":"Chung","year":"2019","journal-title":"Transplantation"},{"key":"10.1016\/j.canlet.2023.216406_bib42","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1111\/bjd.20974","article-title":"Topical treatment of actinic keratoses in organ transplant recipients: a feasibility study for SPOT (Squamous cell carcinoma Prevention in Organ transplant recipients using Topical treatments)","volume":"187","author":"Hasan","year":"2022","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.canlet.2023.216406_bib43","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.det.2019.02.004","article-title":"Topical and systemic modalities for chemoprevention of nonmelanoma skin cancer","volume":"37","author":"Nemer","year":"2019","journal-title":"Dermatol. Clin."},{"key":"10.1016\/j.canlet.2023.216406_bib44","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1684\/ejd.2010.1010","article-title":"Results of a randomized, placebo-controlled safety and efficacy study of topical diclofenac 3% gel in organ transplant patients with multiple actinic keratoses","volume":"20","author":"Ulrich","year":"2010","journal-title":"Eur. J. Dermatol."},{"key":"10.1016\/j.canlet.2023.216406_bib45","doi-asserted-by":"crossref","DOI":"10.3389\/ti.2022.10880","article-title":"Interventions after first post-transplant cutaneous squamous cell carcinoma: a proposed decision framework","volume":"35","author":"Bottomley","year":"2022","journal-title":"Transpl. Int."},{"key":"10.1016\/j.canlet.2023.216406_bib46","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1067\/S0190-9622(03)01831-0","article-title":"Acitretin treatment of premalignant and malignant skin disorders in renal transplant recipients: clinical effects of a randomized trial comparing two doses of acitretin","volume":"49","author":"de Sevaux","year":"2003","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.canlet.2023.216406_bib47","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1200\/JCO.1995.13.8.1933","article-title":"Prevention of skin cancer and reduction of keratotic skin lesions during acitretin therapy in renal transplant recipients: a double-blind, placebo-controlled study","volume":"13","author":"Bavinck","year":"1995","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.canlet.2023.216406_bib48","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1111\/j.1751-1097.2010.00746.x","article-title":"Nicotinamide prevents ultraviolet radiation-induced cellular energy loss","volume":"86","author":"Park","year":"2010","journal-title":"Photochem. Photobiol."},{"key":"10.1016\/j.canlet.2023.216406_bib49","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1056\/NEJMoa1506197","article-title":"A phase 3 randomized trial of nicotinamide for skin-cancer chemoprevention","volume":"373","author":"Chen","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.canlet.2023.216406_bib50","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20082009","article-title":"The role of the immune system in cutaneous squamous cell carcinoma","volume":"20","author":"Bottomley","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.canlet.2023.216406_bib51","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1111\/j.1365-2133.2011.10507.x","article-title":"Roles of the immune system in skin cancer","volume":"165","author":"Rangwala","year":"2011","journal-title":"Br. J. Dermatol."},{"issue":"Suppl s1","key":"10.1016\/j.canlet.2023.216406_bib52","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1111\/ajt.15672","article-title":"OPTN\/SRTR 2018 annual data report: kidney","volume":"20","author":"Hart","year":"2020","journal-title":"Am. J. Transplant. : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons"},{"key":"10.1016\/j.canlet.2023.216406_bib53","doi-asserted-by":"crossref","first-page":"160","DOI":"10.3389\/fonc.2019.00160","article-title":"Dissecting the Multiplicity of Immune Effects of Immunosuppressive Drugs to Better Predict the Risk of de novo Malignancies in Solid Organ Transplant Patients","volume":"9","author":"Cangemi","year":"2019","journal-title":"Front. Oncol."},{"key":"10.1016\/j.canlet.2023.216406_bib54","doi-asserted-by":"crossref","first-page":"2090","DOI":"10.1097\/01.TP.0000058808.37349.23","article-title":"Mycophenolate mofetil-based immunosuppression and cytokine genotypes: effects on monokine secretion and antigen presentation in long-term renal transplant recipients","volume":"75","author":"Weimer","year":"2003","journal-title":"Transplantation"},{"key":"10.1016\/j.canlet.2023.216406_bib55","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1046\/j.1365-2249.2003.02269.x","article-title":"Mycophenolate mofetil inhibits differentiation, maturation and allostimulatory function of human monocyte-derived dendritic cells","volume":"134","author":"Colic","year":"2003","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.canlet.2023.216406_bib56","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1097\/CJI.0b013e3181cc2615","article-title":"Immunosuppression affects CD4+ mRNA expression and induces Th2 dominance in the microenvironment of cutaneous squamous cell carcinoma in organ transplant recipients","volume":"33","author":"Kosmidis","year":"2010","journal-title":"J. Immunother."},{"key":"10.1016\/j.canlet.2023.216406_bib57","article-title":"Increased Tc22 and Treg\/CD8 ratio contribute to aggressive growth of transplant associated squamous cell carcinoma","volume":"8","author":"Zhang","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.canlet.2023.216406_bib58","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/s41698-020-0119-9","article-title":"Decreased cytotoxic T cells and TCR clonality in organ transplant recipients with squamous cell carcinoma","volume":"4","author":"Frazzette","year":"2020","journal-title":"npj Precis. Oncol."},{"key":"10.1016\/j.canlet.2023.216406_bib59","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1038\/s41586-019-1719-9","article-title":"Immunity to commensal papillomaviruses protects against skin cancer","volume":"575","author":"Strickley","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.canlet.2023.216406_bib60","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1111\/j.0022-202X.2005.23904.x","article-title":"UVA radiation impairs phenotypic and functional maturation of human dermal dendritic cells","volume":"125","author":"Furio","year":"2005","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.canlet.2023.216406_bib61","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1039\/b418378a","article-title":"Ultraviolet B radiation-induced immunosuppression: molecular mechanisms and cellular alterations","volume":"4","author":"Schade","year":"2005","journal-title":"Photochem. Photobiol. Sci. : Offic. J. European Photochem. Assoc. Eur. Soci. Photobiol."},{"key":"10.1016\/j.canlet.2023.216406_bib62","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1093\/carcin\/bgt486","article-title":"Tumor-promoting role of TGFbeta1 signaling in ultraviolet B-induced skin carcinogenesis is associated with cutaneous inflammation and lymph node migration of dermal dendritic cells","volume":"35","author":"Ravindran","year":"2014","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.canlet.2023.216406_bib63","doi-asserted-by":"crossref","first-page":"2824","DOI":"10.1038\/jid.2015.207","article-title":"Langerhans cells facilitate UVB-induced epidermal carcinogenesis","volume":"135","author":"Lewis","year":"2015","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.canlet.2023.216406_bib64","doi-asserted-by":"crossref","first-page":"2128","DOI":"10.1111\/jdv.13151","article-title":"Peritumoral dermis of squamous cell carcinomas in renal transplant recipients contains less CD11c+ myeloid dendritic cells and FoxP3+ T cells compared to immunocompetent controls","volume":"29","author":"Sandvik","year":"2015","journal-title":"J. Eur. Acad. Dermatol. Venereol. : JEADV"},{"key":"10.1016\/j.canlet.2023.216406_bib65","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1111\/j.1365-2559.2009.03324.x","article-title":"Progression of cutaneous squamous cell carcinoma in immunosuppressed patients is associated with reduced CD123+ and FOXP3+ cells in the perineoplastic inflammatory infiltrate","volume":"55","author":"Muhleisen","year":"2009","journal-title":"Histopathology"},{"key":"10.1016\/j.canlet.2023.216406_bib66","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.abd.2020.08.006","article-title":"Plasmacytoid dendritic cells in dermatology","volume":"96","author":"Dias de Oliveira","year":"2021","journal-title":"An. Bras. Dermatol."},{"key":"10.1016\/j.canlet.2023.216406_bib67","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/s41590-017-0022-x","article-title":"Myeloid-derived suppressor cells coming of age","volume":"19","author":"Veglia","year":"2018","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.canlet.2023.216406_bib68","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.jdermsci.2016.04.013","article-title":"Cutaneous squamous cell carcinomas with markers of increased metastatic risk are associated with elevated numbers of neutrophils and\/or granulocytic myeloid derived suppressor cells","volume":"83","author":"Seddon","year":"2016","journal-title":"J. Dermatol. Sci."},{"key":"10.1016\/j.canlet.2023.216406_bib69","first-page":"44","article-title":"Topical imiquimod therapy for actinic keratosis: is long-term clearance a realistic benefit?","volume":"1","year":"2008","journal-title":"J Clin Aesthet Dermatol"},{"key":"10.1016\/j.canlet.2023.216406_bib70","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/j.jaad.2022.05.051","article-title":"A comparison of invasive squamous cell carcinoma greater than 1 year after treatment with 5-fluorouracil, imiquimod, or photodynamic therapy with aminolevulinic acid","volume":"87","author":"Cheng","year":"2022","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.canlet.2023.216406_bib71","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S1068-607X(98)00034-1","article-title":"Percutaneous penetration of Aldara cream, 5% during the topical treatment of genital and perianal warts","volume":"5","author":"Owens","year":"1998","journal-title":"Prim. Care Update OB\/GYNS"},{"key":"10.1016\/j.canlet.2023.216406_bib72","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1159\/000323737","article-title":"Acute renal failure caused by imiquimod 5% cream in a renal transplant patient: review of the literature on side effects of imiquimod","volume":"222","author":"Santos-Juanes","year":"2011","journal-title":"Dermatology"},{"key":"10.1016\/j.canlet.2023.216406_bib73","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1172\/JCI89820","article-title":"Randomized trial of calcipotriol combined with 5-fluorouracil for skin cancer precursor immunotherapy","volume":"127","author":"Cunningham","year":"2017","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.canlet.2023.216406_bib74","first-page":"4","article-title":"Skin cancer precursor immunotherapy for squamous cell carcinoma prevention","author":"Rosenberg","year":"2019","journal-title":"JCI Insight"},{"key":"10.1016\/j.canlet.2023.216406_bib75","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1080\/09546634.2017.1373737","article-title":"Psoriasis in solid organ transplant patients: best practice recommendations from the Medical Board of the National Psoriasis Foundation","volume":"29","author":"Prussick","year":"2018","journal-title":"J. Dermatol. Treat."},{"key":"10.1016\/j.canlet.2023.216406_bib76","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/j.ccr.2012.08.017","article-title":"Elevated epidermal thymic stromal lymphopoietin levels establish an antitumor environment in the skin","volume":"22","author":"Demehri","year":"2012","journal-title":"Cancer Cell"},{"key":"10.1016\/j.canlet.2023.216406_bib77","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1007\/s10096-019-03508-z","article-title":"Investigation of three oncogenic epitheliotropic viruses shows human papillomavirus in association with non-melanoma skin cancer","volume":"38","author":"Baez","year":"2019","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."}],"container-title":["Cancer Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383523003579?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383523003579?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T16:10:45Z","timestamp":1759594245000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304383523003579"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10]]},"references-count":77,"alternative-id":["S0304383523003579"],"URL":"https:\/\/doi.org\/10.1016\/j.canlet.2023.216406","relation":{},"ISSN":["0304-3835"],"issn-type":[{"value":"0304-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2023,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Skin cancer prevention \u2013 Recent advances and unmet challenges","name":"articletitle","label":"Article Title"},{"value":"Cancer Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canlet.2023.216406","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"216406"}}